The French National Research Agency Projects for science

Version franaise

InformationNews

Preliminary announcement: a call for European projects on Systems medicine.

The French National Research Agency will launch, in partnership with 11 countries, the second ERACoSysMed joint call for funding multilateral research projects on Systems Medicine. The call is scheduled to be open on the February 3rd 2017.

The call aims to support the development of projects fostering the implementation of Systems Medicine approaches, in both, clinical research and medical practice, by funding a number of high quality research projects that will improve our current knowledge of human health and disease.

New paths for clinical research

Demonstrator projects should start with an idea or concept that addresses a clear medical or clinical need. It is expected that project outcomes will lead to new paths for clinical research aimed at delivering better and more efficient and personalised prevention, diagnostics and treatments of human diseases.

Projects should within their envisaged duration, substantiate the translation of Systems Medicine into medical research and practice by focusing on high quality data sets and clinical relevance. Furthermore they should define new innovative approaches and tools that enable the integration of biological and clinical data that will lead to the creation of new and/or improved computational models. The added value to the Systems Medicine field should be demonstrated.

Datasets for the proposed research areas should be already available before the implementation of the project. However, these datasets may be complemented and/or validated during the execution of the project.

This call for proposals includes funding research organizations of 12 countries: Austria, Belgium, France, Germany, Israel, Italy, Luxembourg, Netherlands, Norway, Slovakia, Slovenia and Spain.

Consortium composition

Joint research proposals may be submitted by higher education institutions, non-university public research establishments, hospitals as well as commercial companies, in particular small and medium-size enterprises (SMEs), according to relevant national funding regulations.

Only transnational projects will be funded. Each consortium must involve a minimum of three and a maximum of five eligible partners from at least three different countries participating to the call. No more than two eligible partners from the same country are allowed to join each consortium. External collaborators, i.e. groups from countries that are not participating in this call, or research groups from countries that are partners in this joint transnational call but do not ask for funding, may participate in projects, provided that they demonstrate in advance that their economic and human resources have already been secured (i.e. prior to the full-proposal submission) and will be available at the start of the project. The maximum number of external collaborators per consortium is two.
In order to strengthen the implementation of Systems Medicine throughout Europe, the inclusion of research teams from Slovenia and Slovakia is encouraged. Therefore, consortia including partners from these two countries may increase the maximum number of eligible partners to seven or nine in cases involving two external collaborators.

Each transnational collaborative project should represent the critical mass to achieve the scientific goals, the translation of Systems Medicine approaches into medical research and practice, and to clearly demonstrate an added value from working together. Clinical expertise is mandatory in order to ensure an efficient transfer of results into clinical application.

In addition, each project proposal must meet the following conditions:

  • Projects can be funded for a period of up to three years and according to national funding organisations’ regulations.
  • Have effective multidisciplinary collaboration involving, both, clinical and translational researchers, medical doctors, epidemiologists, bioinformaticians, data management experts and where possible patient representatives and industry. Each consortium submitting a proposal must include at least one clinical partner, one computational biologist and, where possible, industry.
  • Fulfil the legal and ethical international/EU and national and institutional standards.
  • Provide a well-designed and feasible Data Management Plan based on the following five principles: Security, Findability, Accessibility, Interoperability and Re-usability.

 

ERACoSysMed

Systems medicine is a relatively new and promising field, combining life science approaches with information science ones.  An interdisciplinary field of study, it integrates biological and medical data with mathematical and computational models, with the aim of understanding the underlying mechanisms behind diseases and thus developing new preventive measures, diagnosis and personalised treatment strategies (P4 medicine).

In this context, the ERACoSysMed programme aims to reinforce the European scientific community in the field of systems medicine and on related research themes. As an ERA-NET Cofund supported by the European Commission in the framework of Horizon 2020, it gathers fourteen partner funding agencies which intend to launch calls for European projects on these topics.

 

Estimated schedule

Submission and evaluation of projects will be carried out in two stages and integrated with other countries. Each country shall fund its national teams according to its own procedures.

The call is scheduled to open on February 3rd, 2017.

For more information

30.11.16